Herpes Zoster Vaccine (Zostavax) Revisited

被引：0

|

作者：

不详

机构：

来源：

MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2010年 / 52卷 / 1339期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：41 / 41

页数：1

相关论文

共 50 条

[1] Herpes zoster vaccine (Zostavax)
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1243): : 73 - 74
[2] Effectiveness of the herpes zoster vaccine Zostavax
Lai, Shih-Wei
[J]. VACCINE, 2020, 38 (52) : 8258 - 8258
[3] Zostavax: a subcutaneous vaccine for the prevention of herpes zoster
Doan, Hung Q.
Ung, Bothland
Ramirez-Fort, Marigdalia K.
Khan, Farhan
Tyring, Stephen K.
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (10) : 1467 - 1477
[4] Herpes zoster virus vaccine (Zostavax) for the prevention of shingles
deYoung, G. Robert
Baty, Philip J.
[J]. AMERICAN FAMILY PHYSICIAN, 2007, 75 (12) : 1843 - 1844
[5] Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
Gillian M. Keating
[J]. BioDrugs, 2016, 30 : 243 - 254
[6] Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
Keating, Gillian M.
[J]. BIODRUGS, 2016, 30 (03) : 243 - 254
[7] Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden
Blom, Kim
Yin, Li
Arnheim-Dahlstrom, Lisen
[J]. VACCINE, 2019, 37 (31) : 4401 - 4406
[8] Herpes zoster vaccine (Zostavax®): Cellulitic injection site reaction or bacterial cellulitis?
Cook, Ian F.
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (04) : 784 - 785
[9] Zoster Vaccine (Zostavax®) A Review of its Use in Preventing Herpes Zoster and Postherpetic Neuralgia in Older Adults
Sanford, Mark
Keating, Gillian M.
[J]. DRUGS & AGING, 2010, 27 (02) : 159 - 176
[10] Zoster Vaccine (Zostavax®)A Review of its Use in Preventing Herpes Zoster and Postherpetic Neuralgia in Older Adults
Mark Sanford
Gillian M. Keating
[J]. Drugs & Aging, 2010, 27 : 159 - 176

← 1 2 3 4 5 →